PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 7:49 AM ET

Sponsor Check › Person

JB
No photo found yet (own website and image search run after this page is viewed)

Jeff Baxter

Named as an officer, director or promoter on SEC Form D filings · MA, CA · Jul 15, 2011 → May 27, 2020

4deals (issuers)
$79.3Mreported sold
141investors
28Form D filings
2011–2020years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:24 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Jeff Baxter is listed as an executive officer and director on 28 SEC Form D filings by 4 issuers between Jul 2011 and Mar 2021: VBI VACCINES INC. (Cambridge, MA — biotechnology — 2014–2015; $36.4M reported sold to 27 investors), ChromaDex Corp. (Los Angeles, CA — biotechnology — 2016–2021; $25M reported sold to 45 investors), VBI Vaccines Inc/BC (Cambridge, MA — pharmaceuticals — 2016–2020; $13.6M reported sold to 61 investors) and Variation Biotechnologies (US), Inc. (Cambridge, MA — biotechnology — 2011–2014; $4.33M reported sold to 8 investors).

What this means A repeat sponsor — 4 separate companies raised money with this person listed as executive officer and director, over about 10 years. Across those companies the filings report $79.3M sold in total.

Listed alongside Egidio Nascimento (14 shared filings), David Anderson (11 shared filings), Michael Steinmetz (11 shared filings), Frank L. Jaksch (10 shared filings), Kurt Gustafson (9 shared filings) and 53 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Jeff. Each name links to their own page.

The issuers belong to 2 sponsor groups: Vbi Vaccines (2 issuers, $6.29M reported sold, 2010–2022) and Chromadex (2 issuers, $3.1M reported sold, 2010–2022).

What this means This person is listed across more than one sponsor team; each group page shows that team's full track record.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 2 bankruptcy cases matching the name listed in Key records below.

What this means 2 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 28 public filings for Jeff Baxter and found 11 differences, 3 worth asking the sponsor about: Regulator action naming a team member: Hugh Dunkerley (Jun 13, 2019); Bankruptcy case: Jeff W Baxter and Helen J. Baxter; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Jeff Baxter has not run yet — it is joining a line of 27,905 names; searches run around the clock at the hosts' allowed rate. Searched so far: 638 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:24 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: VA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Jeff Baxter..

State securities regulators: Securities regulators searched (3,318 actions): AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE DOJ Investor Protection Unit (257 actions, 1987–2026), TX State Securities Board (586 actions, 2006–2026), WA DFI (2,039 actions, 2001–2026) — last crawled Oct 23, 2026, 9:57 PM ET. No machine-readable public listing today for CO, FL, IA, IN, MN, NE, NJ, NY, OH, UT, VA (see docs/state-regulators.md).

3. Bankruptcies

2 cases: 2 closed (disposition not in docket feed)

Jeff W Baxter and Helen J. Baxter closed
United States Bankruptcy Court, D. Massachusetts · No. 17-12221 · Filed Jun 12, 2017 · Closed Oct 10, 2018
Role of Jeff W Baxter and Helen J. Baxter: Debtor · Outcome: Case closed 2018-10-10 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 9 federal dockets); court in the person's filing state (MA)
Jeff Baxter closed
United States Bankruptcy Court, N.D. Alabama · No. 08-71575 · Filed Jul 31, 2008 · Closed Sep 10, 2009
Role of Jeff Baxter: Debtor · Outcome: Case closed 2009-09-10 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 9 federal dockets); court in AL (not a filing state)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:24 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

11 differences found between the filings for Jeff Baxter — 3 worth asking about (compared 28 filings on Oct 24, 2026)

Worth asking · Jun 13, 2019

Regulator action naming a team member: Hugh Dunkerley (Jun 13, 2019)

A ap release dated Jun 13, 2019 names Hugh Dunkerley (listed on the same filings). Our match estimate: 80%. The release is the source; we do not summarize its outcome here.

What this means A regulator filed or announced an action naming this person or company (or someone on the same filings). Read the release; ask the sponsor what it was and how it ended.

Hugh Dunkerley ↗Hugh Dunkerley — PartnerFacts page ↗
Sources
Worth asking · Jun 12, 2017 – Oct 10, 2018

Bankruptcy case: Jeff W Baxter and Helen J. Baxter — filed Jun 12, 2017

United States Bankruptcy Court, D. Massachusetts docket "Jeff W Baxter and Helen J. Baxter" filed Jun 12, 2017, closed Oct 10, 2018. Jeff Baxter is listed as Debtor ("Jeff W Baxter and Helen J. Baxter"). Our match estimate: 50%.

What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.

Docket · United States Bankruptcy Court, D. Massachusetts ↗
Sources
Note · Mar 15, 2010 – Jul 12, 2010

Bankruptcy case: Wesley Yan and Wendy Yu — filed Mar 15, 2010

United States Bankruptcy Court, E.D. California docket "Wesley Yan and Wendy Yu" filed Mar 15, 2010, closed Jul 12, 2010. Wendy Yu (listed on the same filings) is listed as Debtor ("Wesley Yan and Wendy Yu"). Our match estimate: 70%.

What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.

Docket · United States Bankruptcy Court, E.D. California ↗Wendy Yu — PartnerFacts page ↗
Sources
Note · May 12, 1998 – Aug 25, 1998

Bankruptcy case: Joanne M. Cordeiro — filed May 12, 1998

United States Bankruptcy Court, D. Massachusetts docket "Joanne M. Cordeiro" filed May 12, 1998, closed Aug 25, 1998. Joanne Cordeiro (listed on the same filings) is listed as Debtor ("Joanne M. Cordeiro"). Our match estimate: 70%.

What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.

Docket · United States Bankruptcy Court, D. Massachusetts ↗Joanne Cordeiro — PartnerFacts page ↗
Sources
Note · Aug 8, 2014

16% of the money raised went to insiders — VBI VACCINES INC.

The Aug 8, 2014 Form D reports $11,000,000 sold and $1,762,300 of the proceeds used for payments to officers, directors or promoters (marked as an estimate). Issuer's note: "Approximately $1,762,300 of the proceeds from the offering will be used to pay executive officer salaries and board compensation.".

What this means The filing reports how much of the money raised was paid to insiders. Over 10% is high for most deals. Ask what it paid for.

Form D · Aug 8, 2014 ↗VBI VACCINES INC. — PartnerFacts page ↗
Sources
Note · Mar 25, 2014

17% of the money raised went to insiders — Variation Biotechnologies (US), Inc.

The Mar 25, 2014 Form D reports $1,500,000 sold and $250,000 of the proceeds used for payments to officers, directors or promoters (marked as an estimate). Issuer's note: "Approx. $250K in ordinary course compensation and board fees to be paid to named officers and directors.".

What this means The filing reports how much of the money raised was paid to insiders. Over 10% is high for most deals. Ask what it paid for.

Form D · Mar 25, 2014 ↗Variation Biotechnologies (US), Inc. — PartnerFacts page ↗
Sources
Worth asking · Nov 17, 2010 – Dec 24, 2013

5 Form Ds were filed more than 15 days after the first sale

Form D filed 85 days after the first sale — Variation Biotechnologies (US), Inc. · Form D filed 240 days after the first sale — Variation Biotechnologies (US), Inc. · Form D filed 16 days after the first sale — Variation Biotechnologies (US), Inc. · Form D filed 58 days after the first sale — Variation Biotechnologies (US), Inc. · Form D filed 42 days after the first sale — Variation Biotechnologies (US), Inc.

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Form D · Dec 24, 2013 ↗Variation Biotechnologies (US), Inc. — PartnerFacts page ↗Form D · Jul 15, 2011 ↗Form D · Nov 9, 2012 ↗
Sources
Note · Jul 15, 2011 – Mar 16, 2016

Jeff Baxter is written 2 different ways on the filings

listed as "Jeff Baxter" on 27 filings (from Jul 15, 2011), and "Jeff 10005 Muirlands Blvd., Suite G Baxter" on the Mar 16, 2016 filing.

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D · Jul 15, 2011 ↗Form D · Mar 16, 2016 ↗Jeff Baxter — PartnerFacts page ↗
Sources
Note · Jul 5, 2016 – Dec 7, 2018

Industry group changed between filings — VBI Vaccines Inc/BC

"Biotechnology" (Jul 5, 2016 to Dec 20, 2016); then "Pharmaceuticals" (Dec 7, 2018 to May 27, 2020).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Jul 5, 2016 ↗Form D · Dec 7, 2018 ↗VBI Vaccines Inc/BC — PartnerFacts page ↗
Sources
Note · Nov 29, 2017 – May 24, 2019

Address moved from Irvine, CA to Los Angeles, CA — ChromaDex Corp.

The people listed on the Nov 29, 2017 filing give Irvine, CA; on the May 24, 2019 filing they give Los Angeles, CA. The address now on file (10900 Wilshire Blvd, Suite 600, Los Angeles, CA) is a registered-agent or shared-office address used by 6 issuers.

What this means A registered agent's address is a mailbox, not where the team works. Ask where the business actually operates.

Form D · Nov 29, 2017 ↗Form D · May 24, 2019 ↗ChromaDex Corp. — PartnerFacts page ↗
Sources
Note · Jul 15, 2011 – Mar 3, 2021

Jeff Baxter is listed with 2 different address states: MA, CA

MA on 18 filings (Jul 15, 2011 to May 27, 2020); CA on 10 filings (Mar 16, 2016 to Mar 3, 2021).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D · Jul 15, 2011 ↗Form D · Mar 16, 2016 ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

5 of 28 offerings report sales commissions totalling $1,157,500; 2 report finder's fees totalling $500,000; 2 report proceeds to related persons totalling $2,012,300. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Mar 3, 2021 D
ChromaDex Corp.
File 021-391071
$0$0$0None listed on this filingEDGAR ↗
May 27, 2020 D
VBI Vaccines Inc/BC
File 021-367784
$0$0$0None listed on this filingEDGAR ↗
May 20, 2020 D
ChromaDex Corp.
File 021-367407
$0$0$0None listed on this filingEDGAR ↗
May 1, 2020 D
VBI Vaccines Inc/BC
File 021-366112
$0$0$0None listed on this filingEDGAR ↗
Aug 29, 2019 D
ChromaDex Corp.
File 021-347602
$175,000$0$0Oppenheimer & Co. Inc. BrokerCheck CRD 105559 ↗EDGAR ↗
May 24, 2019 D
ChromaDex Corp.
File 021-340389
$250,000$0$0Oppenheimer & Co. Inc. BrokerCheck CRD 105559 ↗EDGAR ↗
Dec 7, 2018 D
VBI Vaccines Inc/BC
File 021-327445
$0$0$0None listed on this filingEDGAR ↗
Nov 29, 2017 D
ChromaDex Corp.
File 021-299636
$0$0$0None listed on this filingEDGAR ↗
Aug 31, 2017 D
ChromaDex Corp.
File 021-293893
$0$0$0Ladenburg Thalmann and Co. Inc. BrokerCheck CRD 505 ↗
via Ladenburg Thalmann and Co. Inc. (CRD 505 ↗)
EDGAR ↗
Jun 6, 2017 D
ChromaDex Corp.
File 021-288093
$0$255,000$0Ladenburg Thalmann and Co. Inc. BrokerCheck CRD 505 ↗
via Ladenburg Thalmann and Co. Inc. (CRD 505 ↗)
EDGAR ↗
May 5, 2017 D
ChromaDex Corp.
File 021-286157
$0$245,000$0Ladenburg Thalmann and Co. Inc. BrokerCheck CRD 505 ↗
via Ladenburg Thalmann and Co. Inc. (CRD 505 ↗)
EDGAR ↗
Mar 22, 2017 D
ChromaDex Corp.
File 021-283036
$0$0$0None listed on this filingEDGAR ↗
Dec 20, 2016 D
VBI Vaccines Inc/BC
File 021-276702
$0$0$0
While no offering proceeds are set aside for payments to the named officers or directors, it is possible that some proceeds to be used as working capital will be used indirectly for paying salaries to employees including executive officers.
None listed on this filingEDGAR ↗
Jul 5, 2016 D
VBI Vaccines Inc/BC
File 021-266313
$0$0$0 (est.)None listed on this filingEDGAR ↗
Mar 16, 2016 D
ChromaDex Corp.
File 021-259415
$0$0$0None listed on this filingEDGAR ↗
Aug 26, 2015 D
VBI VACCINES INC.
File 021-246473
$0$0$0 (est.)None listed on this filingEDGAR ↗
Aug 8, 2014 D
VBI VACCINES INC.
File 021-222563
$300,000$0$1,762,300 (est.)
Approximately $1,762,300 of the proceeds from the offering will be used to pay executive officer salaries and board compensation.
Middlebury Securities, LLC BrokerCheck CRD 122602 ↗
via Middlebury Securities, LLC (CRD 122602 ↗)
EDGAR ↗
Aug 8, 2014 D
VBI VACCINES INC.
File 021-222565
$367,500$0$0 (est.)None listed on this filingEDGAR ↗
Mar 25, 2014 D
Variation Biotechnologies (US), Inc.
File 021-214214
$65,000$0$250,000 (est.)
Approx. $250K in ordinary course compensation and board fees to be paid to named officers and directors.
Middlebury Securities, LLC BrokerCheck CRD 122602 ↗
via Middlebury Securities, LLC (CRD 122602 ↗)

Palladium Capital Advisors, LLC BrokerCheck CRD 129400 ↗
via Palladium Capital Advisors, LLC (CRD 129400 ↗)
EDGAR ↗
Dec 24, 2013 D
Variation Biotechnologies (US), Inc.
File 021-208713
$0$0$0None listed on this filingEDGAR ↗
Sep 10, 2013 D
Variation Biotechnologies (US), Inc.
File 021-202580
$0$0$0None listed on this filingEDGAR ↗
Jun 20, 2013 D
Variation Biotechnologies (US), Inc.
File 021-198327
$0$0$0None listed on this filingEDGAR ↗
Mar 8, 2013 D
Variation Biotechnologies (US), Inc.
File 021-192997
$0$0$0None listed on this filingEDGAR ↗
Nov 9, 2012 D
Variation Biotechnologies (US), Inc.
File 021-186732
$0$0$0None listed on this filingEDGAR ↗
Jun 29, 2012 D
Variation Biotechnologies (US), Inc.
File 021-180572
$0$0$0None listed on this filingEDGAR ↗
Feb 10, 2012 D
Variation Biotechnologies (US), Inc.
File 021-173278
$0$0$0None listed on this filingEDGAR ↗
Jul 15, 2011 D
Variation Biotechnologies (US), Inc.
File 021-162993
$0$0$0None listed on this filingEDGAR ↗
Jul 15, 2011 D
Variation Biotechnologies (US), Inc.
File 021-162994
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 4

Every issuer that named Jeff Baxter on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

CC
Biotechnology · group: Chromadex

ChromaDex Corp.

Los Angeles, CA · Mar 16, 2016 → Mar 3, 2021 · 10 filings
  • Mar 3, 2021 · D · $24,999,995 sold of $24,999,995 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 20, 2020 · D · $5,000,000 sold of $5,000,000 · 2 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 29, 2019 · D · $7,000,000 sold of $7,000,000 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 24, 2019 · D · $10,000,000 sold of $10,000,000 · 2 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 29, 2017 · D · $22,999,996 sold of $22,999,996 · 10 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 31, 2017 · D · $5,110,084 sold of $5,110,084 · 2 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 6, 2017 · D · $16,389,916 sold of $16,389,916 · 2 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 5, 2017 · D · $3,500,000 sold of $3,500,000 · 2 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 22, 2017 · D · $1,000,003 sold of $1,000,003 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 16, 2016 · D · $500,000 sold of $500,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $25M from 45 investors (100% of the $25M target) as of the latest filing. Jeff is listed as director on 10 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

VV
Pharmaceuticals · group: Vbi Vaccines

VBI Vaccines Inc/BC

Cambridge, MA · Jul 5, 2016 → May 27, 2020 · 5 filings
  • May 27, 2020 · D · $4,700,000 sold of $4,700,000 · 1 investors · min. No minimum reported · role: Executive Officer, Director (President and Chief Executive Officer, Director) EDGAR ↗
  • May 1, 2020 · D · $1,057,500 sold of $1,057,500 · 61 investors · min. No minimum reported · role: Executive Officer, Director (President and Chief Executive Officer, Director) EDGAR ↗
  • Dec 7, 2018 · D · $7,000,000 sold of $7,000,000 · 1 investors · min. No minimum reported · role: Executive Officer, Director (Chief Executive Officer and Director) EDGAR ↗
  • Dec 20, 2016 · D · $10,598,750 sold of $10,598,750 · 2 investors · min. No minimum reported · role: Executive Officer, Director (CHIEF EXECUTIVE OFFICER AND PRESIDENT) EDGAR ↗
  • Jul 5, 2016 · D · $13,609,749 sold of $13,609,749 · 3 investors · min. No minimum reported · role: Executive Officer, Director (CHIEF EXECUTIVE OFFICER AND PRESIDENT) EDGAR ↗

Raised $13.6M from 61 investors (100% of the $4.7M target) as of the latest filing. Jeff is listed as executive officer, director on 5 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

VV
Biotechnology · group: Vbi Vaccines

VBI VACCINES INC.

Cambridge, MA · Aug 8, 2014 → Aug 26, 2015 · 3 filings
  • Aug 26, 2015 · D · $6,285,700 sold of $6,285,700 · 19 investors · min. No minimum reported · role: Executive Officer, Director (President and Chief Executive Officer) EDGAR ↗
  • Aug 8, 2014 · D · $36,356,807 sold of $36,356,807 · 27 investors · min. No minimum reported · role: Executive Officer, Director (President and Chief Executive Officer) EDGAR ↗
  • Aug 8, 2014 · D · $11,000,000 sold of $11,000,000 · 6 investors · min. No minimum reported · role: Executive Officer, Director (President and Chief Executive Officer) EDGAR ↗

Raised $36.4M from 27 investors (100% of the $6.29M target) as of the latest filing. Jeff is listed as executive officer, director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

VB
Biotechnology

Variation Biotechnologies (US), Inc.

Cambridge, MA · Jul 15, 2011 → Mar 25, 2014 · 10 filings
  • Mar 25, 2014 · D · $1,500,000 sold of $1,500,000 · 8 investors · min. No minimum reported · role: Executive Officer, Director (Chief Executive Officer, President and Director) EDGAR ↗
  • Dec 24, 2013 · D · $1,375,000 sold of $1,375,000 · 2 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Sep 10, 2013 · D · $250,000 sold of $250,000 · 2 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Jun 20, 2013 · D · $750,000 sold of $750,000 · 2 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Mar 8, 2013 · D · $751,061 sold of $751,061 · 4 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Nov 9, 2012 · D · $1,200,000 sold of $1,200,000 · 4 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Jun 29, 2012 · D · $1,200,000 sold of $1,200,000 · 4 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Feb 10, 2012 · D · $2,200,000 sold of $2,200,000 · 4 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Jul 15, 2011 · D · $3,500,000 sold of $3,500,000 · 4 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Jul 15, 2011 · D · $4,331,932 sold of $4,331,932 · 4 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $4.33M from 8 investors (100% of the $1.5M target) as of the latest filing. Jeff is listed as executive officer, director on 10 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

People around Jeff 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

EN
No photo found yet (own website and image search run after this page is viewed)
Person

Egidio Nascimento

Executive Officer · 14 shared filings (3 issuers)

Listed on the same filings as Jeff Baxter. Their page shows their other deals.

MS
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Steinmetz

Director · 11 shared filings (2 issuers) · also on 5 other issuers

Michael Steinmetz is on 7 issuers in total — a repeat sponsor. Their page lists every one.

DA
No photo found yet (own website and image search run after this page is viewed)
Person

David Anderson

Executive Officer · 11 shared filings (3 issuers) · also on 2 other issuers

David Anderson is on 5 issuers in total — a repeat sponsor. Their page lists every one.

FJ
No photo found yet (own website and image search run after this page is viewed)
Person

Frank L. Jaksch

Executive Officer, Director · 10 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Jeff Baxter. Their page shows their other deals.

RF
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Fried

Executive Officer, Director · 9 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Jeff Baxter. Their page shows their other deals.

KG
No photo found yet (own website and image search run after this page is viewed)
Person

Kurt Gustafson

Director · 9 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Jeff Baxter. Their page shows their other deals.

SR
No photo found yet (own website and image search run after this page is viewed)
Person

Steven Rubin

Director · 8 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Jeff Baxter. Their page shows their other deals.

SG
No photo found yet (own website and image search run after this page is viewed)
Person

Steve Gillis

Director · 7 shared filings (3 issuers) · also on 12 other issuers

Steve Gillis is on 15 issuers in total — a repeat sponsor. Their page lists every one.

SG
No photo found yet (own website and image search run after this page is viewed)
Person

Stephen Gillis

Director · 6 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Jeff Baxter. Their page shows their other deals.

MK
No photo found yet (own website and image search run after this page is viewed)
Person

Marc J. Kirchmeier

Executive Officer · 6 shared filings (2 issuers)

Listed on the same filings as Jeff Baxter. Their page shows their other deals.

MW
No photo found yet (own website and image search run after this page is viewed)
Person

Michel De Wilde

Director · 6 shared filings (2 issuers)

Listed on the same filings as Jeff Baxter. Their page shows their other deals.

TR
No photo found yet (own website and image search run after this page is viewed)
Person

Troy Rhonemus

Executive Officer · 6 shared filings (1 issuer)

Listed on the same filings as Jeff Baxter. Their page shows their other deals.

SR
No photo found yet (own website and image search run after this page is viewed)
Person

Scott Rocklage

Director · 5 shared filings (1 issuer) · also on 17 other issuers

Scott Rocklage is on 18 issuers in total — a repeat sponsor. Their page lists every one.

SG
No photo found yet (own website and image search run after this page is viewed)
Person

Steven Gillis

Director · 5 shared filings (2 issuers) · also on 28 other issuers

Steven Gillis is on 30 issuers in total — a repeat sponsor. Their page lists every one.

SV
No photo found yet (own website and image search run after this page is viewed)
Person

Steve Vignau

Director · 5 shared filings (1 issuer)

Listed on the same filings as Jeff Baxter. Their page shows their other deals.

KF
No photo found yet (own website and image search run after this page is viewed)
Person

Kevin Forrest

Director · 5 shared filings (1 issuer)

Listed on the same filings as Jeff Baxter. Their page shows their other deals.

SC
No photo found yet (own website and image search run after this page is viewed)
Person

Sam Chawla

Director · 5 shared filings (2 issuers)

Listed on the same filings as Jeff Baxter. Their page shows their other deals.

KF
No photo found yet (own website and image search run after this page is viewed)
Person

Kevin M. Farr

Executive Officer · 5 shared filings (1 issuer)

Listed on the same filings as Jeff Baxter. Their page shows their other deals.

SB
No photo found yet (own website and image search run after this page is viewed)
Person

Stephen A. Block

Director · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Jeff Baxter. Their page shows their other deals.

MF
No photo found yet (own website and image search run after this page is viewed)
Person

Mark Friedman

Executive Officer · 4 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Jeff Baxter. Their page shows their other deals.

TV
No photo found yet (own website and image search run after this page is viewed)
Person

Thomas Varvaro

Executive Officer · 4 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Jeff Baxter. Their page shows their other deals.

TL
No photo found yet (own website and image search run after this page is viewed)
Person

Tony Lau

Director · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Jeff Baxter. Their page shows their other deals.

AB
No photo found yet (own website and image search run after this page is viewed)
Person

Adam Buckley

Executive Officer · 4 shared filings (2 issuers)

Listed on the same filings as Jeff Baxter. Their page shows their other deals.

SA
No photo found yet (own website and image search run after this page is viewed)
Person

Stephen L. Allen

Director · 4 shared filings (1 issuer)

Listed on the same filings as Jeff Baxter. Their page shows their other deals.

WY
No photo found yet (own website and image search run after this page is viewed)
Person

Wendy Yu

Director · 4 shared filings (1 issuer)

Listed on the same filings as Jeff Baxter. Their page shows their other deals.

TD
No photo found yet (own website and image search run after this page is viewed)
Person

Trent Davis

Director · 3 shared filings (1 issuer) · also on 7 other issuers

Trent Davis is on 8 issuers in total — a repeat sponsor. Their page lists every one.

SV
No photo found yet (own website and image search run after this page is viewed)
Person

Steven Vignau

Director · 3 shared filings (1 issuer)

Listed on the same filings as Jeff Baxter. Their page shows their other deals.

SR
No photo found yet (own website and image search run after this page is viewed)
Person

Scott Requadt

Director · 3 shared filings (1 issuer) · also on 9 other issuers

Scott Requadt is on 10 issuers in total — a repeat sponsor. Their page lists every one.

NB
No photo found yet (own website and image search run after this page is viewed)
Person

Nell Beattie

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Jeff Baxter. Their page shows their other deals.

CM
No photo found yet (own website and image search run after this page is viewed)
Person

Christopher McNulty

Executive Officer, Director · 3 shared filings (1 issuer)

Listed on the same filings as Jeff Baxter. Their page shows their other deals.

AM
No photo found yet (own website and image search run after this page is viewed)
Person

Avi Mazaltov

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Jeff Baxter. Their page shows their other deals.

FM
No photo found yet (own website and image search run after this page is viewed)
Person

Francisco Diaz-Mitoma

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Jeff Baxter. Their page shows their other deals.

SB
No photo found yet (own website and image search run after this page is viewed)
Person

Stephen Block

Director · 3 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Jeff Baxter. Their page shows their other deals.

AT
No photo found yet (own website and image search run after this page is viewed)
Person

Alan Timmins

Director · 3 shared filings (1 issuer)

Listed on the same filings as Jeff Baxter. Their page shows their other deals.

JL
No photo found yet (own website and image search run after this page is viewed)
Person

Jeffrey Leiden

Director · 2 shared filings (1 issuer) · also on 4 other issuers

Jeffrey Leiden is on 5 issuers in total — a repeat sponsor. Their page lists every one.

MR
No photo found yet (own website and image search run after this page is viewed)
Person

Matthew Roberts

Executive Officer · 2 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Jeff Baxter. Their page shows their other deals.

SA
No photo found yet (own website and image search run after this page is viewed)
Person

Steve Allen

Director · 2 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Jeff Baxter. Their page shows their other deals.

TB
No photo found yet (own website and image search run after this page is viewed)
Person

T. Adam Buckley

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Jeff Baxter. Their page shows their other deals.

MD
No photo found yet (own website and image search run after this page is viewed)
Person

Michel DeWilde

Director · 2 shared filings (1 issuer)

Listed on the same filings as Jeff Baxter. Their page shows their other deals.

SR
No photo found yet (own website and image search run after this page is viewed)
Person

STEVEN RUBIN

Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Jeff Baxter. Their page shows their other deals.

The team behind the deals

VV
Sponsor group

Vbi Vaccines

2 issuers · 12 filings · $6.29M reported sold · 2010–2022

One team, 2 deal companies. Jeff Baxter is listed on 2 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Jeff Baxter.

C
Sponsor group

Chromadex

2 issuers · 21 filings · $3.1M reported sold · 2010–2022

One team, 2 deal companies. Jeff Baxter is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Jeff Baxter.

Same business address

18 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

None of the 4 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Jeff Baxter by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 4 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Jeff Baxter is listed on: none on file. No website or social profile named in VBI Vaccines Inc/BC's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #143,701 of 374,652 in line (1,345 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Cambridge, MA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗Massachusetts MassCourts ↗California — find the county court ↗Los Angeles Superior Court case search ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

Massachusetts Secretary of State business search ↗California Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Jeff Baxter appears on a new Form D, or when a court case or SEC action is matched to them. See plans →